ClinicalTrials.gg
Not yet recruitingNCT07826208Updated Sep 17, 2026

Added Diagnostic Value of CT Arthrography to MR Arthrography in Wrist Internal Derangement

An interventional study of Combined CT Arthrography and MR Arthrography in Wrist Internal Derangement, Triangular Fibrocartilage Complex Tears and Scapholunate Ligament Tears, sponsored by Assiut University. Not yet recruiting. Open to participants aged 15 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Assiut University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
15 Years to 60 Years
Sex
All
01

Study summary

The wrist is a complex joint made up of small bones, cartilage, and stabilizing ligaments, including the triangular fibrocartilage complex (TFCC) and intrinsic carpal ligaments. Because these structures are small and intricate, diagnosing internal joint damage (internal derangement) after trauma or chronic pain can be challenging.

Magnetic resonance arthrography (MRA), an imaging scan performed after injecting a contrast dye into the joint, is widely used because it shows soft tissues clearly. However, MRA can sometimes miss subtle bone fragments, cartilage defects, or partial ligament tears due to lower spatial resolution. Computed tomography arthrography (CTA) provides higher-detail spatial imaging and excels at identifying small bone injuries and ligament tears, though it offers less soft-tissue contrast than MRI.

The purpose of this study is to determine whether performing CT arthrography in addition to MR arthrography improves the detection and characterization of internal wrist pathologies compared with MR arthrography alone.

Participants enrolled in this study will:

  • Undergo a clinical history taking and examination regarding their wrist symptoms.
  • Receive an ultrasound-guided injection into the radiocarpal joint using a sterile mixture containing iodinated contrast, gadolinium contrast, saline, and a local numbing medication (xylocaine).
  • Undergo a high-resolution CT scan of the wrist immediately following the injection.
  • Undergo a 1.5T MR arthrography scan.

Researchers will compare the findings between the two imaging techniques to evaluate how often adding CT arthrography identifies additional lesions that were occult or inconclusive on MR arthrography.

02

Conditions studied

  • Wrist Internal Derangement
  • Triangular Fibrocartilage Complex Tears
  • Scapholunate Ligament Tears
  • Lunotriquetral Ligament Tears
  • Wrist Injuries
  • Wrist Instability

Browse trials for

Keywords

  • CT Arthrography
  • MR Arthrography
  • Computed Tomography Arthrography
  • Magnetic Resonance Arthrography
  • Triangular Fibrocartilage Complex
  • Scapholunate Ligament
  • Lunotriquetral Ligament
  • Ultrasound Guided Injection
  • Wrist Joint
  • Carpal Ligaments
03

In context

Wrist Injuries

46 studies on the registry are indexed under Wrist Injuries; 12 are open to participants now.

This study's planned enrollment of 60 is above the median of 53 across 32 interventional studies indexed under Wrist Injuries.

Browse Wrist Injuries studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 15 to 60 years.
  • Clinically suspected ligamentous, cartilage, tendon, or occult osseous wrist injury.
  • Patients scheduled for MR arthrography of the wrist.

Exclusion criteria

Exclusion Criteria:

  • History of previous wrist surgery.
  • Acute fractures requiring emergency management.
  • Active wrist infection.
  • to iodinated or gadolinium-based contrast agents.
  • Regional metallic implants causing significant imaging artifacts.
  • Pregnancy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Combined CT and MR Arthrography

    Participants with clinically suspected wrist internal derangement receive an ultrasound-guided intra-articular injection into the radiocarpal joint using a combined mixture of iodinated contrast, gadolinium-based contrast, sterile saline, and xylocaine. Immediately following the injection, participants undergo high-resolution computed tomography arthrography (HRCT) of the affected wrist. This is followed by 1.5T magnetic resonance arthrography (MRA) with pre-contrast and post-contrast T1 SPIR sequences in axial, coronal, and sagittal planes to assess wrist internal derangement.

    Diagnostic Test: Combined CT Arthrography and MR Arthrography

Interventions

  • Diagnostic testCombined CT Arthrography and MR Arthrography

    Under high-resolution ultrasound guidance, an intra-articular radiocarpal injection of approximately 5 mL is administered using a sterile mixture of iodinated contrast, gadolinium-based contrast, sterile saline, and xylocaine. Immediately following injection, high-resolution CT arthrography is performed with 0.6 mm slice thickness and multiplanar reconstruction in axial, coronal, and sagittal planes. Participants subsequently undergo 1.5T MR arthrography using coronal T2 SPIR (pre-contrast) and axial, coronal, and sagittal T1 SPIR sequences (post-contrast) using a dedicated wrist coil to evaluate internal derangement.

06

What researchers measure

Primary outcomes

  1. Percentage of Patients With Additional Wrist Pathologies Detected by Adding CT Arthrography to MR Arthrography

    Assessed as the proportion of participants in whom CT arthrography identifies additional internal derangement lesions (including intrinsic scapholunate and lunotriquetral ligament tears, central triangular fibrocartilage complex tears, cartilage defects, and occult osseous abnormalities) that were missed, occult, or inconclusive on MR arthrography alone.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07826208
Lead sponsor
Assiut University
Responsible party
Norhan Anwar Kamal El Dein Hussien (Resident of Diagnostic and Interventional Radiology, Assiut University) — Principal investigator
First posted
Sep 17, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion